This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Regulus Therapeutics Inc
RGLS : NASDAQ : Health Care
$15.48 | %
Today's Range: 14.68 - 15.54
Avg. Daily Volume: 1,745,700
12/26/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
RGLS REGULUS THERAPEUTICS INC 16.14 784.47 n/m 8.90 -48.69
IMGN IMMUNOGEN INC 10.85 932.41 n/m 55.88 14.83
ARNA ARENA PHARMACEUTICALS INC 4.04 889.26 n/m 34.30 -55.36
INFI INFINITY PHARMACEUTICALS INC 17.19 838.30 n/m 160.64 n/a
ENTA ENANTA PHARMACEUTICALS INC 44.88 834.95 25.50 47.74 1038.31
BCRX BIOCRYST PHARMACEUTICALS INC 11.09 796.97 n/m 18.73 72.37
OREX OREXIGEN THERAPEUTICS INC 6.29 774.71 n/m 33.43 875.14
FOLD AMICUS THERAPEUTICS INC 7.88 733.69 n/m 1.55 3869.23
TGTX TG THERAPEUTICS INC 15.70 690.23 n/m 0.15 14.28
RNA PROSENSA HOLDING NV 18.78 678.26 n/m 23.16 263.21
AEGR AEGERION PHARMACEUTICALS INC 22.95 652.61 n/m 131.16 445.32
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

RGLS Ind Avg S&P 500
n/m 71.67 19.99

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs